Your browser doesn't support javascript.
loading
The association of insomnia with long COVID: An international collaborative study (ICOSS-II).
Chen, Si-Jing; Morin, Charles M; Ivers, Hans; Wing, Yun Kwok; Partinen, Markku; Merikanto, Ilona; Holzinger, Brigitte; Espie, Colin A; De Gennaro, Luigi; Dauvilliers, Yves; Chung, Frances; Yordanova, Juliana; Vidovic, Domagoj; Reis, Catia; Plazzi, Giuseppe; Penzel, Thomas; Nadorff, Michael R; Matsui, Kentaro; Mota-Rolim, Sergio; Leger, Damien; Landtblom, Anne-Marie; Korman, Maria; Inoue, Yuichi; Hrubos-Strøm, Harald; Chan, Ngan Yin; Bjelajac, Adrijana Koscec; Benedict, Christian; Bjorvatn, Bjørn.
Afiliação
  • Chen SJ; Centre de Recherche CERVO/Brain Research Center, École de Psychologie, Université Laval, Quebec City, Quebec, Canada; Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Morin CM; Centre de Recherche CERVO/Brain Research Center, École de Psychologie, Université Laval, Quebec City, Quebec, Canada. Electronic address: cmorin@psy.ulaval.ca.
  • Ivers H; Centre de Recherche CERVO/Brain Research Center, École de Psychologie, Université Laval, Quebec City, Quebec, Canada.
  • Wing YK; Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Partinen M; Department of Clinical Neurosciences, Clinicum, University of Helsinki, Helsinki, Finland; Helsinki Sleep Clinic, Terveystalo Healthcare, Helsinki, Finland.
  • Merikanto I; Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Holzinger B; Institute for Consciousness and Dream Research, Medical University of Vienna, Wien, Postgraduate Sleep Coaching, Vienna, Austria.
  • Espie CA; Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • De Gennaro L; Department of Psychology, Sapienza University of Rome, Roma, Lazio, Italy; IRCCS Fondazione Santa Lucia, Roma, Italy.
  • Dauvilliers Y; Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Institute for Neurosciences of Montpellier INM, INSERM, University of Montpellier, Montpellier, France.
  • Chung F; Department of Anesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Yordanova J; Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Vidovic D; University Psychiatric Hospital Vrapce, Bolnicka Cesta 32, 10000, Zagreb, Croatia.
  • Reis C; Universidade Católica Portuguesa, Católica Research Centre for Psychological-Family and Social Wellbeing, Lisbon, Portugal; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal; Instituto de Saúde Ambiental, Faculdade de Medicin
  • Plazzi G; IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Penzel T; Sleep Medicine Center, Charite University Hospital Berlin, Berlin, Germany.
  • Nadorff MR; Department of Psychology, Mississippi State University, Mississippi State, MS, USA.
  • Matsui K; Department of Clinical Laboratory, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Mota-Rolim S; Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Leger D; APHP, Hôtel-Dieu, Centre du Sommeil et de la Vigilance, Paris, France; Université Paris Cité, VIFASOM (EA 7331 Vigilance Fatigue Sommeil et Santé Publique), Paris, France.
  • Landtblom AM; Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden; Department of Biomedical and Clinical Sciences, Linköping University, Sweden.
  • Korman M; Department of Occupational Therapy, Faculty of Health Sciences, Ariel University, Ariel, Israel.
  • Inoue Y; Department of Somnology, Tokyo Medical University, Tokyo, Japan; Japan Somnology Center, Institute of Neuropsychiatry, Tokyo, Japan.
  • Hrubos-Strøm H; Department of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Chan NY; Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Bjelajac AK; Institute for Medical Research and Occupational Health, Zagreb, Croatia.
  • Benedict C; Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, Uppsala, Sweden.
  • Bjorvatn B; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.
Sleep Med ; 112: 216-222, 2023 12.
Article em En | MEDLINE | ID: mdl-37922783
ABSTRACT

OBJECTIVE:

There is evidence of a strong association between insomnia and COVID-19, yet few studies have examined the relationship between insomnia and long COVID. This study aimed to investigate whether COVID-19 patients with pre-pandemic insomnia have a greater risk of developing long COVID and whether long COVID is in turn associated with higher incident rates of insomnia symptoms after infection.

METHODS:

Data were collected cross-sectionally (May-Dec 2021) as part of an international collaborative study involving participants from 16 countries. A total of 2311 participants (18-99 years old) with COVID-19 provided valid responses to a web-based survey about sleep, insomnia, and health-related variables. Log-binomial regression was used to assess bidirectional associations between insomnia and long COVID. Analyses were adjusted for age, sex, and health conditions, including sleep apnea, attention and memory problems, chronic fatigue, depression, and anxiety.

RESULTS:

COVID-19 patients with pre-pandemic insomnia showed a higher risk of developing long COVID than those without pre-pandemic insomnia (70.8% vs 51.4%; adjusted relative risk [RR] 1.33, 95% confidence interval [CI] 1.07-1.65). Among COVID-19 cases without pre-pandemic insomnia, the rates of incident insomnia symptoms after infection were 24.1% for short COVID cases and 60.6% for long COVID cases (p < .001). Compared with short COVID cases, long COVID cases were associated with an increased risk of developing insomnia symptoms (adjusted RR 2.00; 95% CI 1.50-2.66).

CONCLUSIONS:

The findings support a bidirectional relationship between insomnia and long COVID. These findings highlight the importance of addressing sleep and insomnia in the prevention and management of long COVID.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Distúrbios do Início e da Manutenção do Sono Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Distúrbios do Início e da Manutenção do Sono Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article